Toxoplasmosis infection in newborn: A systematic review and meta-analysis

Background: Toxoplasmosis is a disease caused by Toxoplasma gondii, and one-third of the world's population has T. gondii antibodies. Due to this issue, the aim of this study was to assess the mean prevalence and odds ratios of T. gondii infection and epidemiological features of neonatal infect...

Full description

Bibliographic Details
Main Authors: Mehran Akbari, Davood Azadi, Danial Habibi, Sahar Khodashenas, Fakhreddin Shariatmadari, Behnam Abedi
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2022-01-01
Series:Advanced Biomedical Research
Subjects:
Online Access:http://www.advbiores.net/article.asp?issn=2277-9175;year=2022;volume=11;issue=1;spage=75;epage=75;aulast=Akbari
_version_ 1811239409373151232
author Mehran Akbari
Davood Azadi
Danial Habibi
Sahar Khodashenas
Fakhreddin Shariatmadari
Behnam Abedi
author_facet Mehran Akbari
Davood Azadi
Danial Habibi
Sahar Khodashenas
Fakhreddin Shariatmadari
Behnam Abedi
author_sort Mehran Akbari
collection DOAJ
description Background: Toxoplasmosis is a disease caused by Toxoplasma gondii, and one-third of the world's population has T. gondii antibodies. Due to this issue, the aim of this study was to assess the mean prevalence and odds ratios of T. gondii infection and epidemiological features of neonatal infection worldwide. Materials and Methods: We performed a meta-analysis and systematic review of published studies reporting T. gondii infection using the PubMed, MEDLINE, Web of Science, EMBASE, and Scopus electronic databases through January 1999 to December 2020, regarding diagnostic tests, and prevalence data of infection among the newborn population. The pooled prevalence of T. gondii with a 95% confidence interval (CI) was calculated using the random-effects models. Results: A total of thirty eligible articles were included. The estimated global prevalence rate was 44% (95% CI: 29%–0.58%); the highest prevalence rate was in America 47% (95% CI: 30%–64%), followed by Europe 41% (95% CI: 26%–57%) and Asia 33% (95% CI: 4%–61%). In this study, despite our careful analysis of possible modifiers, the heterogeneity was significant (P = 0.000). The publication bias was not significant based on the results of Egger's (P = 0.918) and Begg's tests (P = 0.230). Conclusion: Based on the results of this study, T. gondii infection can be a serious concern in newborns around the world. Therefore, further research is needed to provide better strategies to screen and diagnose T. gondii infection in neonates and determine the risk factors associated with the prevalence of infection in neonates worldwide.
first_indexed 2024-04-12T12:59:29Z
format Article
id doaj.art-8b28527d9b864e6c8fee7839ec496594
institution Directory Open Access Journal
issn 2277-9175
language English
last_indexed 2024-04-12T12:59:29Z
publishDate 2022-01-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Advanced Biomedical Research
spelling doaj.art-8b28527d9b864e6c8fee7839ec4965942022-12-22T03:32:13ZengWolters Kluwer Medknow PublicationsAdvanced Biomedical Research2277-91752022-01-01111757510.4103/abr.abr_24_21Toxoplasmosis infection in newborn: A systematic review and meta-analysisMehran AkbariDavood AzadiDanial HabibiSahar KhodashenasFakhreddin ShariatmadariBehnam AbediBackground: Toxoplasmosis is a disease caused by Toxoplasma gondii, and one-third of the world's population has T. gondii antibodies. Due to this issue, the aim of this study was to assess the mean prevalence and odds ratios of T. gondii infection and epidemiological features of neonatal infection worldwide. Materials and Methods: We performed a meta-analysis and systematic review of published studies reporting T. gondii infection using the PubMed, MEDLINE, Web of Science, EMBASE, and Scopus electronic databases through January 1999 to December 2020, regarding diagnostic tests, and prevalence data of infection among the newborn population. The pooled prevalence of T. gondii with a 95% confidence interval (CI) was calculated using the random-effects models. Results: A total of thirty eligible articles were included. The estimated global prevalence rate was 44% (95% CI: 29%–0.58%); the highest prevalence rate was in America 47% (95% CI: 30%–64%), followed by Europe 41% (95% CI: 26%–57%) and Asia 33% (95% CI: 4%–61%). In this study, despite our careful analysis of possible modifiers, the heterogeneity was significant (P = 0.000). The publication bias was not significant based on the results of Egger's (P = 0.918) and Begg's tests (P = 0.230). Conclusion: Based on the results of this study, T. gondii infection can be a serious concern in newborns around the world. Therefore, further research is needed to provide better strategies to screen and diagnose T. gondii infection in neonates and determine the risk factors associated with the prevalence of infection in neonates worldwide.http://www.advbiores.net/article.asp?issn=2277-9175;year=2022;volume=11;issue=1;spage=75;epage=75;aulast=Akbarimeta-analysisnewbornprevalencesystematic reviewtoxoplasma gondii
spellingShingle Mehran Akbari
Davood Azadi
Danial Habibi
Sahar Khodashenas
Fakhreddin Shariatmadari
Behnam Abedi
Toxoplasmosis infection in newborn: A systematic review and meta-analysis
Advanced Biomedical Research
meta-analysis
newborn
prevalence
systematic review
toxoplasma gondii
title Toxoplasmosis infection in newborn: A systematic review and meta-analysis
title_full Toxoplasmosis infection in newborn: A systematic review and meta-analysis
title_fullStr Toxoplasmosis infection in newborn: A systematic review and meta-analysis
title_full_unstemmed Toxoplasmosis infection in newborn: A systematic review and meta-analysis
title_short Toxoplasmosis infection in newborn: A systematic review and meta-analysis
title_sort toxoplasmosis infection in newborn a systematic review and meta analysis
topic meta-analysis
newborn
prevalence
systematic review
toxoplasma gondii
url http://www.advbiores.net/article.asp?issn=2277-9175;year=2022;volume=11;issue=1;spage=75;epage=75;aulast=Akbari
work_keys_str_mv AT mehranakbari toxoplasmosisinfectioninnewbornasystematicreviewandmetaanalysis
AT davoodazadi toxoplasmosisinfectioninnewbornasystematicreviewandmetaanalysis
AT danialhabibi toxoplasmosisinfectioninnewbornasystematicreviewandmetaanalysis
AT saharkhodashenas toxoplasmosisinfectioninnewbornasystematicreviewandmetaanalysis
AT fakhreddinshariatmadari toxoplasmosisinfectioninnewbornasystematicreviewandmetaanalysis
AT behnamabedi toxoplasmosisinfectioninnewbornasystematicreviewandmetaanalysis